Sterling inches up against euro, dollar but remains near multi-week lows
The pound was up 0.3% against the dollar at $1.3452, just above last week's eight-week low of $1.33655.
Britain's economic data was mixed on balance last week - the labour market showed signs of a further cooling, while consumer price inflation unexpectedly rose to its highest in more than a year.
A quarter-point rate cut from the Bank of England at its meeting on August 7 remained almost fully priced after the data, with about 50 basis points of easing priced in by the end of the year.
The pound was also up about 0.2% at 86.575 pence per euro , having touched a 14-week low last week.
"We think a rising fiscal risk premium is the main driver of the recent outperformance of EUR/GBP," said Goldman Sachs FX strategists in a note.
Britain remains in a precarious fiscal position, exacerbated earlier this month after the government suffered a major rebellion against welfare reforms which fed doubts about its ability to cut spending.
Many economists and analysts believe the government will have to raise billions of pounds in taxes later this year to meet its fiscal rules as growth remains elusive.
"The pound's struggle to keep pace with the euro this year reflects a shift in market optimism in favour of Germany and the euro zone," said Rabobank senior FX strategist Jane Foley.
"In view of the UK's fiscal concerns, we continue to favour buying EUR/GBP on dips," Foley added.
Deloitte on Monday said its consumer confidence index dropped to its lowest since the first quarter of 2024, reflecting increased worries about job security and income growth.
Retail sales data due on Friday could give a clearer picture on the state of the consumer, while a preliminary survey of purchasing managers on business activity is set for release on Thursday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
20 minutes ago
- Reuters
Siemens reduces stake in Siemens Healthineers to 71.12%
MUNICH, July 31 (Reuters) - Siemens AG ( opens new tab reduced its stake in medical technology company Siemens Healthineers ( opens new tab by nearly 2 percentage points to 71.12%, according to a regulatory filing. Healthineers' CEO Bernd Montag said earlier this year that the company would welcome a stake reduction by its parent company, calling it "very good" for the long term. "We have repeatedly and clearly stated that we will reduce our stake in Siemens Healthineers as part of the acquisitions of Altair and Dotmatics, without prejudice to any strategic decisions," a Siemens spokesperson told Reuters on Thursday.
Reuters
20 minutes ago
- Reuters
AbbVie lifts annual profit forecast on strong demand for newer immunology drugs
July 31 (Reuters) - AbbVie (ABBV.N), opens new tab raised its 2025 profit forecast on Thursday, after beating Wall Street estimates for second-quarter results on strong sales of its newer immunology drugs Skyrizi and Rinvoq. Shares of the drugmaker rose nearly 3% to $195.03 before the bell. The company is pushing Skyrizi and Rinvoq to counter the drop in sales of Humira, as the once-bestselling drug faces competition from several cheaper biosimilars that began hitting the U.S. market in 2023. "We're entering the second half of the year with substantial momentum," said CEO Robert Michael. Skyrizi recorded quarterly sales of $4.42 billion, beating analysts' average estimate of $4 billion, while Rinvoq sales of $2.03 billion surpassed estimates of $1.97 billion, according to data compiled by LSEG. The North Chicago-based drugmaker has spent more than $20 billion on acquisitions since 2023 as Humira lost patent protection. On Wednesday, Bloomberg News reported that AbbVie is in talks to acquire privately held psychiatric disorder drug developer Gilgamesh Pharmaceuticals in a deal worth about $1 billion. Global sales of arthritis treatment Humira, once the world's best-selling drug, came in at $1.18 billion in the second quarter, missing estimates of $1.45 billion. AbbVie's forecast raise comes on the back of the European Union's framework trade deal with the United States, under which all EU-produced pharmaceuticals entering the U.S. will be subject to a 15% tariff. AbbVie has a significant manufacturing presence in Ireland, where it makes its wrinkle treatment Botox. The company now expects adjusted annual profit per share between $11.88 and $12.08, compared with its previous expectations of $11.67 to $11.87. The company earned quarterly adjusted profit per share of $2.97, compared with estimates of $2.88.
South Wales Argus
21 minutes ago
- South Wales Argus
Massive offshore wind farm approved by Scottish Government
Berwick Bank – proposed to be built off the coast of East Lothian – aims to deliver 4.1 gigawatts (GW) of capacity, which is believed to be enough to power every home in Scotland twice over and around 17% of the homes in the UK. The development will feature up to 307 turbines and have two connection points to the grid – one in Dunbar, East Lothian, and another in Blyth, Northumberland. Deputy First Minister Kate Forbes welcomed the approval, saying the Government had given the application 'extremely careful consideration'. Deputy First Minister Kate Forbes said the decision had been as a result of 'extremely careful consideration' (Andrew Milligan/PA) She said: 'The decision to grant consent to Berwick Bank is a major step in Scotland's progress towards achieving net zero and tackling the climate crisis, as well as supporting national energy security and growing our green economy. 'It is also an important decision for Scotland's renewables sector, and this investment will be further built upon through the delivery of Scotland's significant future pipeline of offshore wind projects under the ScotWind and the Innovation and Targeted Oil and Gas leasing rounds. 'We will continue to work closely with the developer and key stakeholders, including those working in fishing and conservation – to minimise the impact of the development on the marine environment and other marine users – and balance the needs of people and nature.' Developers SSE Renewables will have to provide a plan to counter any impact the wind farm may have on seabirds to be approved by ministers. UK Energy Secretary Ed Miliband said the announcement means there have been enough wind farms approved in the UK to meet the Government's ambition of delivering clean power by 2030. Ed Miliband said such approval for offshore wind projects is a 'huge step forward in Britain's energy security and getting bills down for good' (PA) 'We welcome this decision, which puts us within touching distance of our offshore wind targets to deliver clean power by 2030 – boosting our mission to make Britain a clean energy superpower,' he said. 'We need to take back control of our energy and more offshore wind getting the green light marks a huge step forward in Britain's energy security and getting bills down for good. 'But we know there's a lot more work to do and we must go further and faster to get us off the rollercoaster of fossil fuels and make working people better off with clean, homegrown, secure power as part of our Plan for Change.' The UK Government aims to have between 43 and 50GW of energy capacity in offshore wind by the end of the decade, with 15.9GW currently online and a further 28GW having received consent. Stephen Wheeler, the managing director of SSE Renewables, said news of the approval is 'hugely welcome'. He added: 'At over 4GW of potential capacity, Berwick Bank can play a pivotal role in meeting the mission of Clean Power 2030 for the UK and achieving Scotland's decarbonisation and climate action goals. 'Berwick Bank has the potential to rapidly scale-up Scotland's operational renewable energy capacity and can accelerate the delivery of homegrown, affordable and secure clean energy to UK consumers from Scottish offshore wind, helping meet the UK's clean power ambition by 2030.'
